Jersey City, NJ - March 14, 2018 - WallachBeth Capital, a leading provider of institutional execution services, is acting as the sole placement agent for …
Capital Markets
WallachBeth Capital acts as Co-Book-Running Manager for Co-Diagnostics in its Initial Public Offering
NEW YORK, NY— July 17, 2017 — Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has developed and …
WallachBeth Capital acts as Co-Book-Running Manager for AzurRx BioPharma in its Initial Public Offering
NEW YORK, NY— October 19, 2016—AzurRx BioPharma Inc. (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for …